Exploiting the defensive sugars of HIV-1 for drug and vaccine design Autor Scanlan, C, Offer, J, Zitzmann, N, Dwek, R

Emerging principles for the therapeutic exploitation of glycosylation. Autor Dalziel, M, Crispin, M, Scanlan, C, Zitzmann, N, Dwek, R

Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens Autor Dunlop, D, Ulrich, A, Dwek, R, Zitzmann, N, Scanlan, C

Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions. Autor Baruah, K, Bowden, T, Krishna, B, Dwek, R, Crispin, M, Scanlan, C

Selective deactivation of serum IgG: A general strategy for the enhancement of monoclonal antibody receptor interactions Autor Baruah, K, Bowden, T, Krishna, B, Dwek, R, Crispin, M, Scanlan, C

Sugar immunogens Autor Dwek, R, Scanlan, C, Dunlop, D, Mansab, F, Tully, S, Wentworth, P, Zitzmann, N

Liposome treatment of viral infections Autor Dwek, R, Nichita-Branza, N, Petrescu, S, Pollock, S, Rudd, P, Scanlan, C, Zitzmann, N

Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12 Autor Fulton, Z, Doores, K, Scanlan, C, Wormald, M, Dwek, R, Wilson, I, Davis, B

Antigenic mimicry of the HIV envelope by AIDS-associated pathogens. Autor Dunlop, D, Ulrich, A, Appelmelk, B, Burton, D, Dwek, R, Zitzmann, N, Scanlan, C

Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens Autor Doores, K, Bonomelli, C, Harvey, D, Vasiljevic, S, Dwek, R, Burton, D, Crispin, M, Scanlan, C

P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope Autor Dwek R, Burton D, Smith D, Zitzmann N, Doores K, Mansab F, Dunlop DC, Scanlan C

Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope Autor Dunlop, D, Mansab, F, Doores, K, Zitzmann, N, Smith, D, Burton, D, Dwek, R, Scanlan, C

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. Autor Bonomelli, C, Doores, K, Dunlop, D, Thaney, V, Dwek, R, Burton, D, Crispin, M, Scanlan, C

A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity Autor Doores, K, Fulton, Z, Scanlan, C, Wormald, M, Dwek, R, Wilson, I, Burton, DR, Davis, B

Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies Autor Yu, X, Baruah, K, Harvey, D, Vasiljevic, S, Alonzi, D, Song, B, Higgins, M, Bowden, T, Scanlan, C, Crispin, M

An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling. Autor Goodfellow, J, Baruah, K, Yamamoto, K, Bonomelli, C, Krishna, B, Harvey, D, Crispin, M, Scanlan, C, Davis, B

Redirecting adenoviruses to tumour cells using therapeutic antibodies: generation of a versatile human bispecific adaptor Autor Vasiljevic, S, Beale, E, Bonomelli, C, Easthope, I, Pritchard, L, Seabright, G, Caputo, A, Scanlan, C, Dalziel, M, Crispin, M

Use of the α-mannosidase I inhibitor kifunensine allows the crystallization of apo CTLA-4 homodimer produced in long-term cultures of Chinese hamster ovary cells Autor Yu, C, Crispin, M, Sonnen, A, Harvey, D, Chang, V, Evans, E, Scanlan, C, Stuart, D, Gilbert, R, Davis, S

A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind... Autor Astronomo, R, Lee, H, Scanlan, C, Pantophlet, R, Huang, C, Wilson, I, Blixt, O, Dwek, R, Wong, C, Burton, DR

A novel form of carbohydrate recognition. The broadly neutralizing anti-HIV-1 antibody 2G12 recognizes a cluster of a1-2 mannose residues on the outer face of GP120 Autor Rudd, P, Scanlan, C, Pantophlet, R, Wormald, M, Saphire, E, Stanfield, R, Wilson, I, Katinger, H, Dwek, R, Burton, DR